Use of biologics to treat relapsing and/or refractory polyarteritis nodosa: data from a European collaborative study.

Rheumatology (Oxford, England)(2022)

引用 2|浏览20
暂无评分
摘要
These results suggest that TCZ may be effective in relapsing and/or refractory PAN. Our data warrant further study to confirm these findings.
更多
查看译文
关键词
Polyarteritis nodosa,TNF-α,biologics,blocker,rituximab,tocilizumab
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要